Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors

NCT02015728 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Childhood Brain Tumor

Interventions

DEVICE: Tumor biology testing
DRUG: Temozolomide
DRUG: Etoposide
DRUG: Sorafenib
DRUG: Everolimus
DRUG: Erlotinib
DRUG: Dasatinib

Sponsor

Seattle Children's Hospital

Collaborators

[object Object]